ILIAS Biologics Inc.
Sangchul Kim has served over 30 years in finance and venture capital industry, developing multiple early-stage venture companies through Initial Public Offering process. He joined ILIAS from Peptron Inc., where he served as Executive Vice President. Sangchul started his career with an investment company KTB Network, He then served as CFO of Bioneer, the first Korean biotech company, and successfully managed its IPO. At ILIAS, Sangchul provides strategic guidance on investor relations and corporate development.
Sangchul received his bachelor's degree from Seoul National University.
This person is not in any offices
ILIAS Biologics Inc.
2 followers
At ILIAS Biologics, they dedicate themselves to the development of paradigm-shifting advances in human medicine. Their platform technology, EXPLOR, makes it possible to load large therapeutic molecules into exosomes, and they are actively developing various therapeutic exosomes, Exo-Targets, as potential treatments for sepsis, pre-term birth, and various hard-to-treat diseases in inflammatory and metabolic areas.